Equitable Trust’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$710K	Buy	6,245 +1,710	+38%	+$194K	0.04%	272
2025 Q1	$477K	Buy	4,535 +755	+20%	+$79.4K	0.03%	313
2024 Q4	$405K	Sell	3,780 -300	-7%	-$32.1K	0.02%	360
2024 Q3	$408K	Hold	4,080	–	–	0.03%	346
2024 Q2	$344K	Buy	+4,080	New	+$344K	0.02%	358